FA
BIOX icon

Friess Associates’s Bioceres Crop Solutions BIOX Stock Holding History

Friess Associates’s Portfolio BIOX Stock Details BIOX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q2 		$1.66M Sell
121,129
-48,525
-29% -$644K 2.77% 22
2022
Q1 		$2.31M Sell
169,654
-9,170
-5% -$121K 1.23% 37
2021
Q4 		$2.53M Sell
178,824
-14,694
-8% -$203K 0.99% 43
2021
Q3 		$2.61M Buy
193,518
+79,434
+70% +$1.07M 1.1% 38
2021
Q2 		$1.6M Buy
+114,084
New +$1.61M 0.6% 64

Other funds holding BIOX

SP
Solel Partners Boston, Massachusetts $468M AUM 2.45% 1-Year Est. Return
UIC
Uniplan Investment Counsel Milwaukee, Wisconsin $974M AUM 21.37% 1-Year Est. Return
APA
Arisaig Partners (Asia) Singapore $2.17M AUM 37.47% 1-Year Est. Return
Allianz Asset Management
Allianz Asset Management Munich, Germany $95.4B AUM 38.74% 1-Year Est. Return
PSCM
Prince Street Capital Management New York $40.3M AUM 0.66% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
RA
Royce & Associates New York $10.1B AUM 42.88% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Ameriprise
Ameriprise Minneapolis, Minnesota $432B AUM 30.22% 1-Year Est. Return

Friess Associates's BIOX Position: Q2 2022 in Review

Friess Associates reduced its Bioceres Crop Solutions (BIOX) stake by 29% in Q2 2022, selling an estimated $644K and leaving 121,129 shares worth $1.66M. The position accounts for 2.77% of the portfolio, ranked #22.

Friess Associates first reported a position in BIOX in Q2 2021 and has held it in 5 quarters since. The position peaked at $2.61M in Q3 2021. 27 funds tracked by Wall St. Rank hold BIOX as of Q2 2022.

  • Friess Associates held 121,129 shares of Bioceres Crop Solutions worth $1.66M as of Q2 2022.
  • Friess Associates sold 48,525 Bioceres Crop Solutions shares in Q2 2022, an estimated $644K.
  • Bioceres Crop Solutions made up 2.77% of Friess Associates's portfolio in Q2 2022, its #22 holding.
  • Friess Associates first reported a position in Bioceres Crop Solutions in Q2 2021 and has held it in 5 quarters since.
  • Friess Associates's Bioceres Crop Solutions position peaked at $2.61M in Q3 2021.
  • 27 funds tracked by Wall St. Rank held Bioceres Crop Solutions as of Q2 2022.

Based on Friess Associates's 13F filing for Q2 2022, filed 15 Aug 2022.